People: Accelerate Diagnostics Inc (AXDX.O)
14 Mar 2014
Dr. Matthew W. Strobeck, Ph.D., is an Independent Director of Accelerate Diagnostics Inc., since July 7, 2012. He currently serves as a director of Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics, chemicals and energy industries. He was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck was a fellow in the Department of Biology at MIT from December 2001 to June 2002. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|